FCIVX | TOLSX | FCIVX / TOLSX | |
Total Expense Ratio | 0.65 | 1.11 | 59% |
Annual Report Gross Expense Ratio | 0.78 | 1.21 | 64% |
Fund Existence | 9 years | 17 years | - |
Gain YTD | 17.114 | 10.734 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 2500 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 86.8M | 910M | 10% |
Annual Yield % from dividends | 3.11 | 2.32 | 134% |
Returns for 1 year | 2.74 | 14.97 | 18% |
Returns for 3 years | -12.87 | 4.82 | -267% |
Returns for 5 years | 10.99 | 18.85 | 58% |
Returns for 10 years | N/A | 42.35 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BSCRX | 17.30 | 0.19 | +1.11% |
Brandes Small Cap Value R6 | |||
FITIX | 21.88 | 0.14 | +0.64% |
Fidelity Advisor Mid Cap II M | |||
JHLVX | 54.55 | 0.30 | +0.55% |
JHancock Fundamental Large Cap Core C | |||
MNECX | 20.39 | 0.08 | +0.39% |
Manning & Napier Pro-Blend Extnd Term L | |||
LHCVX | 18.63 | 0.05 | +0.27% |
Lord Abbett Health Care R6 |